Position in CHRS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$352,800
-$73,080 QoQ
Shares Held
252,000
0.0% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 145 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Derivatives in CHRS
reported options exposure · as of Dec 31, 2024CallValue
$262,338
CallShares
190,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. CHRS ranks #53 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,357,042 | $110,693,915 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $80,947,193 | |
| 3 | IMTX |
Immatics N.V.
|
6,506,802 | $65,913,904 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
2,010,534 | $62,849,292 | |
| 5 | CGON |
CG Oncology, Inc.
|
769,947 | $54,704,734 | |
| 6 | ARGX |
Argenx SE
|
45,068 | $41,812,738 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
929,626 | $31,040,212 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
466,258 | $26,679,282 |
All Filings in CHRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $352,800 | 252,000 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $425,880 | 252,000 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $561,169 | 395,190 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $534,025 | 325,625 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $232,183 | 317,625 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $256,323 | 317,625 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $262,338 | 190,100 | Call | Defined | 2025-02-27 | |
| 2024-12-31 | $424,522 | 307,625 | Shares | Defined | 2025-02-27 | |
| 2024-09-30 | $293,930 | 282,625 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $340,161 | 196,625 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $469,933 | 196,625 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $278,471 | 83,625 | Shares | Defined | 2024-05-06 | |
| 2023-09-30 | $151,937 | 40,625 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $893,475 | 130,625 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $195,030 | 24,625 | Shares | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||